Clinical trials
Phase 3 Musculoskeletal Diseases trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2016 | 3 |
| 2017 | 4 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Active, not recruiting | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AbbVie | 4 |
| BioMarin Pharmaceutical | 3 |
| Amgen | 1 |
| Calcilytix Therapeutics, Inc., a BridgeBio company | 1 |
| Eli Lilly and Company | 1 |
| PTC Therapeutics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Musculoskeletal Diseases | 11 |
| Arthritis | 5 |
| Joint Diseases | 5 |
| Bone Diseases | 4 |
| Genetic Diseases, Inborn | 4 |
| Bone Diseases, Developmental | 3 |
| Dwarfism | 3 |
| Osteochondrodysplasias | 3 |
| Achondroplasia | 2 |
| Arthritis, Psoriatic | 2 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.